✦ LIBER ✦

A double-blind, placebo-controlled, dose escalation safety, and efficacy study of ziac in patients, ages 6–17 years, with hypertension

✍ Scribed by R.J. Cunningham; E.M. Urbina; R.J. Hogg; J.M. Sorof; M. Moxey-Mimms; M.A. Eissa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Darusentan in Pat

✍ Henry R. Black; George L. Bakris; Michael A. Weber; Robert Weiss; Mahfouz El Sha 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 246 KB

Efficacy and Safety of the Selective Ald

✍ Takao Saruta; Shigeru Kageyama; Toshio Ogihara; Kunio Hiwada; Masayo Ogawa; Kazu 📂 Article 📅 2004 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 322 KB

Dose-dependent Safety and Efficacy of Zo

✍ Martin J. Brodie; Roderick Duncan; Herve Vespignani; Andras Solyom; Valeriy Bite 📂 Article 📅 2005 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 170 KB

Effectiveness and safety of ICL670 in ir

✍ Eric Nisbet-Brown; Nancy F Olivieri; Patricia J Giardina; Robert W Grady; Ellis 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 105 KB

A double-blind, placebo-controlled, dose

✍ Beth Soffer; Zhongxin Zhang; Kenneth Miller; Beth A Vogt; Shahnaz Shahinfar 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Efficacy and tolerability of EPs 7630 in

✍ W Kamin; VG Maydannik; FA Malek; M Kieser 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB